Atlas Trials

Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib

Clinical trial NCT00979966 · COMPLETED

Trial details

NCT number
NCT00979966
Sponsor
Central European Society for Anticancer Drug Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-clear Cell Renal Cell Cancer
Start date
2009-07-01
Primary completion
2012-07-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.